Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis

Thomas Berger, Florian Deisenhammer

    The New England Journal of Medicine
    |October 21, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

    Journal of neurology·2026
    Same author

    No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoencephalopathy.

    Journal of the neurological sciences·2026
    Same author

    The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study.

    Journal of neurology·2026
    Same author

    Deep Learning Framework for Automated MRI Planimetry in Multiple Sclerosis.

    International journal of biomedical imaging·2026
    Same author

    Kappa free light chain index in CSF diagnostics: the impact of different immunoglobulin isotypes.

    Frontiers in immunology·2026
    Same author

    Letter in response to "Kappa free light chain index as a substitute to oligoclonal bands in diagnosing multiple sclerosis".

    EBioMedicine·2026